Development of IgA nephropathy following risankizumab therapy for psoriatic arthritis: a case report. [PDF]
Yagasaki M +9 more
europepmc +1 more source
Neuromuscular Defects in a <i>Drosophila</i> Model of the Congenital Disorder of Glycosylation SLC35A2-CDG. [PDF]
Itoh K +4 more
europepmc +1 more source
Gut-kidney axis in IgA nephropathy: mechanisms linking microbiota dysbiosis to immune dysregulation, Gd-IgA1 generation, and renal injury. [PDF]
Mu Z +5 more
europepmc +1 more source
FUT2-mediated intestinal fucosylation: a master regulator of host-microbiota symbiosis in health and disease. [PDF]
Zhao L, Zhang N.
europepmc +1 more source
Glycomic Insights in Gynecological Disease: From Molecular Mechanisms to Precision Diagnostics and Therapeutics. [PDF]
Pásztor R, Váradi C.
europepmc +1 more source
Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma. [PDF]
Cheng JJ +7 more
europepmc +1 more source
IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway. [PDF]
Zhu Y +16 more
europepmc +1 more source
Hydroxychloroquine sulfate for IgA nephropathy: mechanisms and therapeutic potential in improving proteinuria and alleviating disease progression - a literature review. [PDF]
Yilei L +7 more
europepmc +1 more source
Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. [PDF]
Zhou RW +10 more
europepmc +1 more source
Unraveling the glyco-immunity nexus in pancreatic cancer. [PDF]
Rajesh C, Cummings RD, Radhakrishnan P.
europepmc +1 more source

